Demecarium

SENSORY ORGANS

Key facts

Demecarium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1959. DrugCentral lists 1 molecular target, including ACHE.

• Approval status: ofm (first approved 1959 by the FDA).
• Molecular targets: ACHE (1 listed in DrugCentral).
• ATC code: S01EB04 (Parasympathomimetics).
• Molecular formula: C32H52N4O4+2; molecular weight 556.79 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Acetylcholinesterase	ACHE	inhibitor	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1959-08-05	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
S01EB04	SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIGLAUCOMA PREPARATIONS AND MIOTICS › Parasympathomimetics

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Demecarium is on its molecule page.

• Molecular formula: C₃₂H₅₂N₄O₄+2
• Molecular weight: 556.79 g/mol
• CAS number: —
• InChIKey: RWZVPVOZTJJMNU-UHFFFAOYSA-N
• PubChem CID: 5966

CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Demecarium work?

Its molecular targets in DrugCentral include ACHE (inhibitor).

When was Demecarium first approved?

Demecarium was first approved by the FDA in 1959.

What is the chemical formula of Demecarium?

Demecarium has the molecular formula C32H52N4O4+2 and a molecular weight of 556.79 g/mol.

Sources

• DrugCentral drug card 801 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1200514 — compound record and bioactivity
• PubChem CID 5966 — chemical identifiers
• DrugBank DB00944 — drug record
• FDA UNII ILP8XJ8R5K — substance identity
• DailyMed: FDA labels for Demecarium — current prescribing information (label search)
• UniProt P22303 (ACHE) — target protein

How this page is built: methodology · editorial policy & corrections.